Baxter International (NYSE: BAX) reported earnings on July 19. Here are the numbers you need to know.

The 10-second takeaway
For the quarter ended June 30 (Q2), Baxter International beat slightly on revenues and met expectations on earnings per share.

Compared to the prior-year quarter, revenue expanded slightly and GAAP earnings per share increased.

Gross margins increased, operating margins dropped, net margins expanded.

Revenue details
Baxter International reported revenue of $3.57 billion. The 15 analysts polled by S&P Capital IQ expected revenue of $3.53 billion on the same basis. GAAP reported sales were 1.0% higher than the prior-year quarter's $3.54 billion.

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.

EPS details
EPS came in at $1.12. The 19 earnings estimates compiled by S&P Capital IQ anticipated $1.11 per share. GAAP EPS of $1.19 for Q2 were 11% higher than the prior-year quarter's $1.07 per share.

Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.

Margin details
For the quarter, gross margin was 52.4%, 50 basis points better than the prior-year quarter. Operating margin was 21.8%, 170 basis points worse than the prior-year quarter. Net margin was 18.5%, 110 basis points better than the prior-year quarter.

Looking ahead
Next quarter's average estimate for revenue is $3.52 billion. On the bottom line, the average EPS estimate is $1.15.

Next year's average estimate for revenue is $14.19 billion.

Investor sentiment
The stock has a five-star rating (out of five) at Motley Fool CAPS, with 640 members out of 671 rating the stock outperform, and 31 members rating it underperform. Among 198 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 192 give Baxter International a green thumbs-up, and six give it a red thumbs-down.

Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Baxter International is outperform, with an average price target of $61.94.